IPO
Windlas Biotech raises Rs.120-Cr from anchor investors
Gurugram-based Windlas Biotech, a manufacturer of pharmaceutical formulations, has raised over INR 120 crore from anchor investors ahead of its IPO that opens on August 4. The company will allocate 26,18,706 equity shares at INR 460 apiece to 22 funds aggregating to INR 120.46 crore. Among the anchor investors who participated in the bidding are ICICI Prudential Mutual Fund (MF), UTI MF, Sundaram MF, Kuber India Fund, BNP Paribas Arbitrage, Elara India Opportunities Fund and Canara HSBC Oriental Bank of Commerce Life Insurance Company. The IPO comprises fresh issuance of equity shares worth INR 165 crore and an offer for sale (OFS) of up to 5,142,067 equity shares. As a part of the OFS, Vimla Windlass will offload 11.36 lakh equity shares and Tano India Private Equity Fund II will sell 40,06,067 equity shares. SBI Capital Markets, DAM Capital and IIFL Securities are managing the IPO.
From the Venture Intelligence PE-VC Deal Database: In Nov-15, Windlas Biotech raised over $12-M from Tano Capital. (Subscribers to the database can login to view the valuation, deal structuring and other transaction details.)
Want to receive such news items in your inbox? Click Here to sign up for a trial.
